Global Phage Therapy Market Research Report 2025(Status and Outlook)
Description
Report Overview
Phage therapy involves the use of bacteriophages—viruses that specifically target and infect bacteria—to treat bacterial infections, particularly those resistant to conventional antibiotics. This alternative treatment has gained attention due to the rise of antibiotic-resistant bacteria, positioning it as a potential solution in infectious disease management. The market for phage therapy is still in its early stages, primarily driven by research institutions, biotech startups, and a growing number of clinical trials exploring its efficacy against multidrug-resistant pathogens. Key applications include wound infections, gastrointestinal infections, and chronic conditions like cystic fibrosis-related bacterial infections. Regulatory frameworks are evolving, with countries like Georgia, Poland, and the U.S. showing increased interest in clinical adoption. While challenges such as standardization, large-scale production, and regulatory approval remain, the increasing prevalence of antibiotic resistance and the limited pipeline of new antibiotics suggest significant long-term growth potential for phage therapy as a complementary or alternative antimicrobial strategy. Investments in biotechnology and partnerships between academia and pharmaceutical companies are expected to accelerate market development.
The global Phage Therapy market size was estimated at USD 52.34 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 17.78% during the forecast period.
This report provides a deep insight into the global Phage Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Phage Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Phage Therapy market in any manner.
Global Phage Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Market Segmentation (by Type)
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Market Segmentation (by Application)
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Phage Therapy Market
Overview of the regional outlook of the Phage Therapy Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Phage Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Phage Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Phage therapy involves the use of bacteriophages—viruses that specifically target and infect bacteria—to treat bacterial infections, particularly those resistant to conventional antibiotics. This alternative treatment has gained attention due to the rise of antibiotic-resistant bacteria, positioning it as a potential solution in infectious disease management. The market for phage therapy is still in its early stages, primarily driven by research institutions, biotech startups, and a growing number of clinical trials exploring its efficacy against multidrug-resistant pathogens. Key applications include wound infections, gastrointestinal infections, and chronic conditions like cystic fibrosis-related bacterial infections. Regulatory frameworks are evolving, with countries like Georgia, Poland, and the U.S. showing increased interest in clinical adoption. While challenges such as standardization, large-scale production, and regulatory approval remain, the increasing prevalence of antibiotic resistance and the limited pipeline of new antibiotics suggest significant long-term growth potential for phage therapy as a complementary or alternative antimicrobial strategy. Investments in biotechnology and partnerships between academia and pharmaceutical companies are expected to accelerate market development.
The global Phage Therapy market size was estimated at USD 52.34 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 17.78% during the forecast period.
This report provides a deep insight into the global Phage Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Phage Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Phage Therapy market in any manner.
Global Phage Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Market Segmentation (by Type)
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Market Segmentation (by Application)
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Phage Therapy Market
Overview of the regional outlook of the Phage Therapy Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Phage Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Phage Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
168 Pages
- 1 Research Methodology And Statistical Scope
- 1.1 Market Definition And Statistical Scope Of Phage Therapy
- 1.2 Key Market Segments
- 1.2.1 Phage Therapy Segment By Type
- 1.2.2 Phage Therapy Segment By Application
- 1.3 Methodology & Sources Of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown And Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Phage Therapy Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Phage Therapy Market Size (M Usd) Estimates And Forecasts (2020-2033)
- 2.1.2 Global Phage Therapy Sales Estimates And Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size By Region
- 3 Phage Therapy Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Phage Therapy Product Life Cycle
- 3.3 Global Phage Therapy Sales By Manufacturers (2020-2025)
- 3.4 Global Phage Therapy Revenue Market Share By Manufacturers (2020-2025)
- 3.5 Phage Therapy Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
- 3.6 Global Phage Therapy Average Price By Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, And Product Types
- 3.8 Phage Therapy Market Competitive Situation And Trends
- 3.8.1 Phage Therapy Market Concentration Rate
- 3.8.2 Global 5 And 10 Largest Phage Therapy Players Market Share By Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Phage Therapy Industry Chain Analysis
- 4.1 Phage Therapy Industry Chain Analysis
- 4.2 Market Overview Of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development And Dynamics Of Phage Therapy Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 Pest Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Phage Therapy Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions And Their Impacts To Phage Therapy Market
- 5.7 Esg Ratings Of Leading Companies
- 6 Phage Therapy Market Segmentation By Type
- 6.1 Evaluation Matrix Of Segment Market Development Potential (Type)
- 6.2 Global Phage Therapy Sales Market Share By Type (2020-2025)
- 6.3 Global Phage Therapy Market Size Market Share By Type (2020-2025)
- 6.4 Global Phage Therapy Price By Type (2020-2025)
- 7 Phage Therapy Market Segmentation By Application
- 7.1 Evaluation Matrix Of Segment Market Development Potential (Application)
- 7.2 Global Phage Therapy Market Sales By Application (2020-2025)
- 7.3 Global Phage Therapy Market Size (M Usd) By Application (2020-2025)
- 7.4 Global Phage Therapy Sales Growth Rate By Application (2020-2025)
- 8 Phage Therapy Market Sales By Region
- 8.1 Global Phage Therapy Sales By Region
- 8.1.1 Global Phage Therapy Sales By Region
- 8.1.2 Global Phage Therapy Sales Market Share By Region
- 8.2 Global Phage Therapy Market Size By Region
- 8.2.1 Global Phage Therapy Market Size By Region
- 8.2.2 Global Phage Therapy Market Size Market Share By Region
- 8.3 North America
- 8.3.1 North America Phage Therapy Sales By Country
- 8.3.2 North America Phage Therapy Market Size By Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Phage Therapy Sales By Country
- 8.4.2 Europe Phage Therapy Market Size By Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Phage Therapy Sales By Region
- 8.5.2 Asia Pacific Phage Therapy Market Size By Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Phage Therapy Sales By Country
- 8.6.2 South America Phage Therapy Market Size By Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East And Africa
- 8.7.1 Middle East And Africa Phage Therapy Sales By Region
- 8.7.2 Middle East And Africa Phage Therapy Market Size By Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 Uae Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Phage Therapy Market Production By Region
- 9.1 Global Production Of Phage Therapy By Region(2020-2025)
- 9.2 Global Phage Therapy Revenue Market Share By Region (2020-2025)
- 9.3 Global Phage Therapy Production, Revenue, Price And Gross Margin (2020-2025)
- 9.4 North America Phage Therapy Production
- 9.4.1 North America Phage Therapy Production Growth Rate (2020-2025)
- 9.4.2 North America Phage Therapy Production, Revenue, Price And Gross Margin (2020-2025)
- 9.5 Europe Phage Therapy Production
- 9.5.1 Europe Phage Therapy Production Growth Rate (2020-2025)
- 9.5.2 Europe Phage Therapy Production, Revenue, Price And Gross Margin (2020-2025)
- 9.6 Japan Phage Therapy Production (2020-2025)
- 9.6.1 Japan Phage Therapy Production Growth Rate (2020-2025)
- 9.6.2 Japan Phage Therapy Production, Revenue, Price And Gross Margin (2020-2025)
- 9.7 China Phage Therapy Production (2020-2025)
- 9.7.1 China Phage Therapy Production Growth Rate (2020-2025)
- 9.7.2 China Phage Therapy Production, Revenue, Price And Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Npo Microgen
- 10.1.1 Npo Microgen Basic Information
- 10.1.2 Npo Microgen Phage Therapy Product Overview
- 10.1.3 Npo Microgen Phage Therapy Product Market Performance
- 10.1.4 Npo Microgen Business Overview
- 10.1.5 Npo Microgen Swot Analysis
- 10.1.6 Npo Microgen Recent Developments
- 10.2 Proteon Pharmaceuticals
- 10.2.1 Proteon Pharmaceuticals Basic Information
- 10.2.2 Proteon Pharmaceuticals Phage Therapy Product Overview
- 10.2.3 Proteon Pharmaceuticals Phage Therapy Product Market Performance
- 10.2.4 Proteon Pharmaceuticals Business Overview
- 10.2.5 Proteon Pharmaceuticals Swot Analysis
- 10.2.6 Proteon Pharmaceuticals Recent Developments
- 10.3 Phagelux
- 10.3.1 Phagelux Basic Information
- 10.3.2 Phagelux Phage Therapy Product Overview
- 10.3.3 Phagelux Phage Therapy Product Market Performance
- 10.3.4 Phagelux Business Overview
- 10.3.5 Phagelux Swot Analysis
- 10.3.6 Phagelux Recent Developments
- 10.4 Intralytix
- 10.4.1 Intralytix Basic Information
- 10.4.2 Intralytix Phage Therapy Product Overview
- 10.4.3 Intralytix Phage Therapy Product Market Performance
- 10.4.4 Intralytix Business Overview
- 10.4.5 Intralytix Recent Developments
- 10.5 Micreos
- 10.5.1 Micreos Basic Information
- 10.5.2 Micreos Phage Therapy Product Overview
- 10.5.3 Micreos Phage Therapy Product Market Performance
- 10.5.4 Micreos Business Overview
- 10.5.5 Micreos Recent Developments
- 10.6 Eliava Biopreparations
- 10.6.1 Eliava Biopreparations Basic Information
- 10.6.2 Eliava Biopreparations Phage Therapy Product Overview
- 10.6.3 Eliava Biopreparations Phage Therapy Product Market Performance
- 10.6.4 Eliava Biopreparations Business Overview
- 10.6.5 Eliava Biopreparations Recent Developments
- 10.7 Locus Biosciences,Inc
- 10.7.1 Locus Biosciences,Inc Basic Information
- 10.7.2 Locus Biosciences,Inc Phage Therapy Product Overview
- 10.7.3 Locus Biosciences,Inc Phage Therapy Product Market Performance
- 10.7.4 Locus Biosciences,Inc Business Overview
- 10.7.5 Locus Biosciences,Inc Recent Developments
- 10.8 Pharmex Group,Llc
- 10.8.1 Pharmex Group,Llc Basic Information
- 10.8.2 Pharmex Group,Llc Phage Therapy Product Overview
- 10.8.3 Pharmex Group,Llc Phage Therapy Product Market Performance
- 10.8.4 Pharmex Group,Llc Business Overview
- 10.8.5 Pharmex Group,Llc Recent Developments
- 10.9 Pherecydes Pharma
- 10.9.1 Pherecydes Pharma Basic Information
- 10.9.2 Pherecydes Pharma Phage Therapy Product Overview
- 10.9.3 Pherecydes Pharma Phage Therapy Product Market Performance
- 10.9.4 Pherecydes Pharma Business Overview
- 10.9.5 Pherecydes Pharma Recent Developments
- 10.10 Aps Biocontrol Ltd. (Aps)
- 10.10.1 Aps Biocontrol Ltd. (Aps) Basic Information
- 10.10.2 Aps Biocontrol Ltd. (Aps) Phage Therapy Product Overview
- 10.10.3 Aps Biocontrol Ltd. (Aps) Phage Therapy Product Market Performance
- 10.10.4 Aps Biocontrol Ltd. (Aps) Business Overview
- 10.10.5 Aps Biocontrol Ltd. (Aps) Recent Developments
- 10.11 Qingdao Phagepharm Bio-tech
- 10.11.1 Qingdao Phagepharm Bio-tech Basic Information
- 10.11.2 Qingdao Phagepharm Bio-tech Phage Therapy Product Overview
- 10.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Product Market Performance
- 10.11.4 Qingdao Phagepharm Bio-tech Business Overview
- 10.11.5 Qingdao Phagepharm Bio-tech Recent Developments
- 10.12 Fixed-phage Limited
- 10.12.1 Fixed-phage Limited Basic Information
- 10.12.2 Fixed-phage Limited Phage Therapy Product Overview
- 10.12.3 Fixed-phage Limited Phage Therapy Product Market Performance
- 10.12.4 Fixed-phage Limited Business Overview
- 10.12.5 Fixed-phage Limited Recent Developments
- 10.13 Zeptometrix
- 10.13.1 Zeptometrix Basic Information
- 10.13.2 Zeptometrix Phage Therapy Product Overview
- 10.13.3 Zeptometrix Phage Therapy Product Market Performance
- 10.13.4 Zeptometrix Business Overview
- 10.13.5 Zeptometrix Recent Developments
- 10.14 Phage International, Inc.
- 10.14.1 Phage International, Inc. Basic Information
- 10.14.2 Phage International, Inc. Phage Therapy Product Overview
- 10.14.3 Phage International, Inc. Phage Therapy Product Market Performance
- 10.14.4 Phage International, Inc. Business Overview
- 10.14.5 Phage International, Inc. Recent Developments
- 10.15 Micromir
- 10.15.1 Micromir Basic Information
- 10.15.2 Micromir Phage Therapy Product Overview
- 10.15.3 Micromir Phage Therapy Product Market Performance
- 10.15.4 Micromir Business Overview
- 10.15.5 Micromir Recent Developments
- 10.16 Intodeworld, Inc.
- 10.16.1 Intodeworld, Inc. Basic Information
- 10.16.2 Intodeworld, Inc. Phage Therapy Product Overview
- 10.16.3 Intodeworld, Inc. Phage Therapy Product Market Performance
- 10.16.4 Intodeworld, Inc. Business Overview
- 10.16.5 Intodeworld, Inc. Recent Developments
- 10.17 Nextbiotics
- 10.17.1 Nextbiotics Basic Information
- 10.17.2 Nextbiotics Phage Therapy Product Overview
- 10.17.3 Nextbiotics Phage Therapy Product Market Performance
- 10.17.4 Nextbiotics Business Overview
- 10.17.5 Nextbiotics Recent Developments
- 10.18 Armata Pharmaceuticals, Inc.
- 10.18.1 Armata Pharmaceuticals, Inc. Basic Information
- 10.18.2 Armata Pharmaceuticals, Inc. Phage Therapy Product Overview
- 10.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Product Market Performance
- 10.18.4 Armata Pharmaceuticals, Inc. Business Overview
- 10.18.5 Armata Pharmaceuticals, Inc. Recent Developments
- 10.19 Innophage
- 10.19.1 Innophage Basic Information
- 10.19.2 Innophage Phage Therapy Product Overview
- 10.19.3 Innophage Phage Therapy Product Market Performance
- 10.19.4 Innophage Business Overview
- 10.19.5 Innophage Recent Developments
- 10.20 Adaptive Phage Therapeutics
- 10.20.1 Adaptive Phage Therapeutics Basic Information
- 10.20.2 Adaptive Phage Therapeutics Phage Therapy Product Overview
- 10.20.3 Adaptive Phage Therapeutics Phage Therapy Product Market Performance
- 10.20.4 Adaptive Phage Therapeutics Business Overview
- 10.20.5 Adaptive Phage Therapeutics Recent Developments
- 10.21 Technophage
- 10.21.1 Technophage Basic Information
- 10.21.2 Technophage Phage Therapy Product Overview
- 10.21.3 Technophage Phage Therapy Product Market Performance
- 10.21.4 Technophage Business Overview
- 10.21.5 Technophage Recent Developments
- 11 Phage Therapy Market Forecast By Region
- 11.1 Global Phage Therapy Market Size Forecast
- 11.2 Global Phage Therapy Market Forecast By Region
- 11.2.1 North America Market Size Forecast By Country
- 11.2.2 Europe Phage Therapy Market Size Forecast By Country
- 11.2.3 Asia Pacific Phage Therapy Market Size Forecast By Region
- 11.2.4 South America Phage Therapy Market Size Forecast By Country
- 11.2.5 Middle East And Africa Forecasted Sales Of Phage Therapy By Country
- 12 Forecast Market By Type And By Application (2026-2033)
- 12.1 Global Phage Therapy Market Forecast By Type (2026-2033)
- 12.1.1 Global Forecasted Sales Of Phage Therapy By Type (2026-2033)
- 12.1.2 Global Phage Therapy Market Size Forecast By Type (2026-2033)
- 12.1.3 Global Forecasted Price Of Phage Therapy By Type (2026-2033)
- 12.2 Global Phage Therapy Market Forecast By Application (2026-2033)
- 12.2.1 Global Phage Therapy Sales (K Units) Forecast By Application
- 12.2.2 Global Phage Therapy Market Size (M Usd) Forecast By Application (2026-2033)
- 13 Conclusion And Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
